New Partners MTSU, Tecport Optics May Revolutionize Medical Research, Health Care with Diagnostic Tool
October 12, 2016 — Middle Tennessee State University and Tecport Optics of Orlando, Florida, have entered into a licensing agreement to commercialize the University’s biosensor technology as a medical diagnostic tool for research labs and point-of-care health professionals.
“The biosensor technology, which can be applied in the development of a variety of new and innovative sensing equipment, has the capability of revolutionizing medical diagnostics,” said MTSU professor Bill Robertson, the inventor and member of the Department of Physics and Astronomy faculty.
An interdisciplinary team from MTSU including Drs. Robertson, Steve Wright (biology), and Andrienne Frirdli (chemistry) developed the new technology with support from the National Science foundation and Department of Homeland Security.
“The growth of personalized Medicine creates a pressing need for faster and better ways of diagnosing diseases and individual responses to pharmaceutical treatment,” he added. “In addition, drug discovery can be shortened when a rapid (and) more accurate way of screening for biological changes can be used in the process.”
The technology is based on specially designed multilayers, alternating thin films of silicon dioxide and titanium dioxide of precise thickness coated on a glass microscope slide. These multilayers support electromagnetic waves that travel along the surface and detect extremely small changes, such as the addition of one layer of protein or antibody molecules on the slide surface.
On appropriately prepared slides, such changes could indicate the identifiable markers of specific diseases.
“With the increase of disease-resistant bacteria and new stains of viruses killing over 700,000 people worldwide each year, speeding up the drug discovery process is an urgent priority,” Robertson said.
Dr. Nabil El-Hag, Tecport’s Vice Chairman and architect of the strategic relationship, said, “The long-term goal is to use biosensor technology as a mainstay in point-of-care medical diagnostics, not only in doctors’ offices and clinics, but in the local drugstore. This represents an opportunity to participate in the fast-growing $40 billion-plus medical diagnostic market.
“In Third World countries, where access to healthcare is often inaccessible, out biosensor technology could speed up and reduce the cost of diagnosis and treatment,” he said.
Tecport’s “cold palsma” thin film technology allows affordable fabrication of the multilayers, so that they can be used as a disposable supply for a biosensor.
March 7, 2016 — Tam Le, Founder and Chairman of Tecport Optics, today announced the appointment of Dr. Nabil El-Hag as Vice-Chairman of the company. “We are pleased that Dr. El-Hag has rejoined our company. He will be working closely with me on setting the strategic direction of the company, including the development of new strategic alliances that support our growth strategy. Dr. El-Hag was the architect and driving force for establishing our joint venture with teh University of Utah and Axon Corporation a few years ago. He crafted the alliance that enabled us to deploy our cold plasma technology for lens applications for the treatemnt of light sensitive migraine headaches,” said Mr. Le.
The products developed by Axom and Tecport have now reached the final FDA approval stage and Tecport is mobilizing their resources to capitalize on this opportunity. The US migrain market is currently estimated at $2 billion in prescription drug sales. According to a 2001 NIH report, approximately 28 million people suffer from migraines in the US, more than diabetes and asthma combined.
The application of Tecport’s “Polaris Process” is an industry break-through that allows multi-layer thin film coating on plastics. This cold plasma technology opens up a myriad of business opportunities across many market segments. “I am pleased to be working with Tecport during this exciting stage of their growth, and look forward to establishing the strategic alliances that will enable them to capitalize on this revolutionary development in optical technology,” comment Dr. El-Hag.
Dr. El-Hag, an accomplished Fortune 500 executive, an experienced entrepreneur, an award winning scientist, brings over 35 years of unique experience to the venture. “His balanced approach to building value through win-win partnerships, has served is well in the past,” said Mr. Le. “We are confident that Dr. El-Hag’s leadership and business acumen will enable us to realize the tremendous opportunities that cold plasma technology brings to our industry.”
JUST VACUUM Exclusive Distribution Agreement with Tecport Optics
January 10, 2014— JUST VACUUM announces it has entered into an exclusive Distribution Agreement with Tecport Optics, Inc., Orlando, Florida, USA. This Agreement appoints JUST VACUUM as the sole distributor of Tecport coating systems, spare parts and service throughout Europe.
Gerhard Just, General Manager of JUST VACUUM states, “We are already the exclusive distribution and service partner for major component manufacturers in Europe, and we were searching for the right vacuum batch-coating system manufacturer to help us take our business to the next level. After a careful review of candidates, we chose Tecport. During several meetings it became clear that our values of strong technical leadership and an excellent service are similar, and we are excited to be partnering with Tecport.“
Tam Le, President of Tecport Optics expressed that “we are very excited to have finally found a partner that would open up a long awaited European market for us. Tecport has built a strong brand and a nice reputation in the US market for making the most precision coating system. It is time for us to enter the EU market, except that finding the right partner who carries the same enthusiasm about technical advancement in building thin film system, is difficult. After rigorously searching, we feel JUST Vacuum is the partner we have been looking for, who shares the same value of customer support as we do.”